scispace - formally typeset
S

Stéphane Laurent

Researcher at University of Paris

Publications -  428
Citations -  82831

Stéphane Laurent is an academic researcher from University of Paris. The author has contributed to research in topics: Blood pressure & Arterial stiffness. The author has an hindex of 83, co-authored 424 publications receiving 75440 citations. Previous affiliations of Stéphane Laurent include University of Lausanne & Paris Descartes University.

Papers
More filters
Journal ArticleDOI

Glucose level is a major determinant of carotid intima-media thickness in patients with hypertension and hyperglycemia.

TL;DR: It is suggested that glycemia is a major independent determinant of CIMT in hypertensive hyperglycemic patients, not only in DM-2 patients but also at the earlier stage of IFG, offsetting the mechanical role of local pulse pressure.
Journal ArticleDOI

Physician attitudes to blood pressure control: findings from the Supporting Hypertension Awareness and Research Europe-wide survey.

TL;DR: Clinical hesitation in relation to reducing elevated BP to goal levels is putting patients at increased cardiovascular risk and contributing to the substantial health and economic burden associated with uncontrolled BP.
Journal ArticleDOI

Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia

TL;DR: Data indicate the presence of subclinical lesions at arterial sites distant from the renal arteries, suggesting that renal FD is not a focal but a systemic arterial disease.
Journal ArticleDOI

Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis.

TL;DR: Carotid–femoral PWV (cf-PWV) was measured in nine cross-sectional studies and was significantly increased in patients with Crohn's disease and ulcerative colitis and reduced in IBD patients treated with anti-TNF&agr; therapy.
Journal ArticleDOI

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence

TL;DR: A new, large randomized controlled trial is needed to determine the optimal level of BP and LDL-C for the prevention of recurrent stroke and cognitive decline.